SBIRT in New Mexico

新墨西哥州的 SBIRT

基本信息

  • 批准号:
    8518278
  • 负责人:
  • 金额:
    $ 37.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A firm evidence base has emerged supporting screening and brief intervention for alcohol use in healthcare settings. However, important gaps exist in the evidence for screening and brief intervention for illegal drug use. Rigorous research is needed that tests the effectiveness of screening and brief intervention for illegal drug use. In the proposed project, Friends Research Institute is partnering with Sangre de Cristo Community Health Partnership, the organization responsible for implementing the SAMHSA Screening, Brief Intervention, Referral, and Treatment (SBIRT) Initiative at over 35 primary care sites throughout the State of New Mexico since 2003. The proposed study will use a randomized controlled trial to compare the effectiveness of a standardized interpersonal brief intervention (IBI) based on motivational interviewing (currently used in the New Mexico SBIRT initiative) with a promising computerized brief intervention (CBI) in reducing illegal drug use and its associated health consequences. In addition, the study will assess whether patients' computer experience differentially moderates the effectiveness of the two interventions. The study will take place at two large primary care clinics in New Mexico. All patients will complete a screening for substance use via the Alcohol, Tobacco, and Substance Involvement Screening Tool (ASSIST) as part of regular clinical care. Patients who score in a moderate-risk category for illegal drug use (n = 360, 180 at each site) will be randomized within their respective clinics to the IBI or CBI condition. Patients with high-risk drug use will be referred for more intensive services as per standard clinical practice. Primary outcomes include drug use levels for major substances of abuse as measured by radio immunoassay analysis of hair samples, as well as global illicit drug risk ASSIST scores. Secondary outcomes include self-reported frequency of hospitalizations, emergency room utilization, injuries, psychological distress, HIV risk behaviors, arrests, missed work days, and earned income. Data analysis will be conducted using a Generalized Linear Mixed Model approach. An effective computerized brief intervention has the potential to make a substantial impact on SBIRT practice and improve public health. An effective CBI has the potential to offer a more acceptable format for addressing drug use behaviors than an interpersonal encounter, and has the expected advantages of having high reach and easy replication with comparatively lower investment of clinicians' time and resources. PUBLIC HEALTH RELEVANCE: The relevance of this research to public health will show that targeted screening in primary care health settings for moderate drug use will have a significant impact on public health by implementing brief interventions that target risky behaviors in moderate drug using individuals. This research, which also tests the differential effectiveness of two brief interventions for illegal drug use, has the potential to make a significant contribution to understanding the role that brief interventions have in reducing drug use and its associated consequences.
描述(由申请人提供):一个坚实的证据基础已经出现,支持筛查和简短的干预酒精使用在医疗机构。然而,在筛查和短暂干预非法药物使用的证据方面存在着重要的差距。需要进行严格的研究,以检验对非法药物使用进行筛查和短暂干预的有效性。在拟议的项目中,朋友研究所正在与桑格雷德·克里斯托社区卫生伙伴关系合作,该组织自2003年以来负责在新墨西哥州的35多个初级保健站点实施SAMHSA筛查、短暂干预、转诊和治疗(SBIRT)倡议。拟议的研究将采用一项随机对照试验,比较基于动机访谈的标准化人际短暂干预(IBI)(目前在新墨西哥SBIRT计划中使用)与有前景的计算机短暂干预(CBI)在减少非法药物使用及其相关健康后果方面的有效性。此外,该研究将评估患者的电脑体验是否会不同地调节两种干预措施的有效性。这项研究将在新墨西哥州的两家大型初级保健诊所进行。所有患者将通过酒精、烟草和物质介入筛查工具(ASSIST)完成物质使用筛查,作为常规临床护理的一部分。在非法药物使用中评分为中等风险类别的患者(每个站点n = 360,180)将在各自的诊所随机分配到IBI或CBI状况。高危用药患者将按照标准临床做法转诊接受更密集的服务。主要结果包括通过对头发样本进行放射免疫分析来测量主要滥用物质的药物使用水平,以及全球非法药物风险ASSIST评分。次要结局包括自我报告的住院频率、急诊室使用率、伤害、心理困扰、艾滋病毒风险行为、被捕、错过的工作日和收入。数据分析将使用广义线性混合模型方法进行。有效的计算机化简短干预有可能对SBIRT实践产生重大影响,并改善公众健康。有效的CBI有可能提供比人际接触更可接受的解决吸毒行为的格式,并且具有预期的优势,具有高覆盖范围和易于复制,相对较少的临床医生的时间和资源投入。公共卫生相关性:本研究与公共卫生的相关性将表明,在初级保健卫生机构中对中度药物使用进行有针对性的筛查,通过实施针对中度药物使用个体危险行为的简短干预措施,将对公共卫生产生重大影响。这项研究还检验了针对非法药物使用的两种短期干预措施的不同效果,有可能对了解短期干预措施在减少药物使用及其相关后果方面的作用作出重大贡献。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use.
工作人员对计算机提供的针对适度吸毒和酗酒的简短干预的可接受性和适当性的看法。
  • DOI:
    10.1080/02791072.2015.1075631
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Mitchell,ShannonGwin;Monico,LauraB;Gryczynski,Jan;O'Grady,KevinE;Schwartz,RobertP
  • 通讯作者:
    Schwartz,RobertP
Gender and ethnic differences in primary care patients' response to computerized vs. in-person brief intervention for illicit drug misuse.
  • DOI:
    10.1016/j.jsat.2017.10.009
  • 发表时间:
    2018-01
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Gryczynski J;Carswell SB;O'Grady KE;Mitchell SG;Schwartz RP
  • 通讯作者:
    Schwartz RP
Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care.
  • DOI:
    10.1016/j.invent.2016.01.004
  • 发表时间:
    2016-05-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ondersma SJ;Gryczynski J;Mitchell SG;O'Grady KE;Schwartz RP
  • 通讯作者:
    Schwartz RP
Corrigendum to "Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients" [Drug Alcohol Depend. 140 (2014) 213-216].
“儿科患者中 DSM-5 和 DSM-IV 尼古丁、酒精和大麻使用障碍诊断之间的一致性”勘误表 [药物酒精依赖。
  • DOI:
    10.1016/j.drugalcdep.2016.09.012
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Kelly,SharonM;Gryczynski,Jan;Mitchell,ShannonGwin;Kirk,Arethusa;O'Grady,KevinE;Schwartz,RobertP
  • 通讯作者:
    Schwartz,RobertP
SBIRT for adolescent drug and alcohol use: current status and future directions.
  • DOI:
    10.1016/j.jsat.2012.11.005
  • 发表时间:
    2013-05
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Mitchell SG;Gryczynski J;O'Grady KE;Schwartz RP
  • 通讯作者:
    Schwartz RP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT P SCHWARTZ其他文献

ROBERT P SCHWARTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT P SCHWARTZ', 18)}}的其他基金

Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
促进临时美沙酮的实施以增加治疗机会:多地点实施试验
  • 批准号:
    10222634
  • 财政年份:
    2018
  • 资助金额:
    $ 37.51万
  • 项目类别:
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
促进临时美沙酮的实施以增加治疗机会:多地点实施试验
  • 批准号:
    9979810
  • 财政年份:
    2018
  • 资助金额:
    $ 37.51万
  • 项目类别:
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
促进临时美沙酮的实施以增加治疗机会:多地点实施试验
  • 批准号:
    9903626
  • 财政年份:
    2018
  • 资助金额:
    $ 37.51万
  • 项目类别:
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
促进临时美沙酮的实施以增加治疗机会:多地点实施试验
  • 批准号:
    10222028
  • 财政年份:
    2018
  • 资助金额:
    $ 37.51万
  • 项目类别:
Re-engineering Methadone Treatment: A Randomized Clinical Trial
重新设计美沙酮治疗:随机临床试验
  • 批准号:
    8607917
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:
Re-engineering Methadone Treatment: A Randomized Clinical Trial
重新设计美沙酮治疗:随机临床试验
  • 批准号:
    8432868
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:
Re-engineering Methadone Treatment: A Randomized Clinical Trial
重新设计美沙酮治疗:随机临床试验
  • 批准号:
    8129970
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:
Re-engineering Methadone Treatment: A Randomized Clinical Trial
重新设计美沙酮治疗:随机临床试验
  • 批准号:
    8230570
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:
SBIRT in New Mexico
新墨西哥州的 SBIRT
  • 批准号:
    7936363
  • 财政年份:
    2009
  • 资助金额:
    $ 37.51万
  • 项目类别:
SBIRT in New Mexico
新墨西哥州的 SBIRT
  • 批准号:
    8314100
  • 财政年份:
    2009
  • 资助金额:
    $ 37.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了